within Pharmacolibrary.Drugs.ATC.J;

model J01DC12
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 9.266666666666666e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.013900000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.009300000000000001,
    k12             = 11.1,
    k21             = 11.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DC12</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefminox is a second-generation cephalosporin antibiotic, used primarily in the treatment of bacterial infections, particularly those caused by Gram-negative and some Gram-positive organisms. It has been mainly used in East Asia and is not widely approved or used in Western countries today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single intravenous infusion; parameters may vary in patients with renal impairment.</p><h4>References</h4><ol><li><p>Omoto, S, &amp; Watanabe, S (1990). Efficacy of cefminox in the treatment of bacterial infections. <i>International journal of clinical pharmacology research</i> 10(6) 361–368. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2099361/\">https://pubmed.ncbi.nlm.nih.gov/2099361</a></p></li><li><p>Azuma, Y, et al., &amp; Goi, H (1989). [Pharmacokinetics and antimicrobial effect of cefminox in serum and ascitic fluid for experimental purulent peritonitis in mice]. <i>Nihon geka hokan. Archiv fur japanische Chirurgie</i> 58(5) 445–451. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2701930/\">https://pubmed.ncbi.nlm.nih.gov/2701930</a></p></li><li><p>Cho, N, et al., &amp; Fukunaga, K (1985). [Pharmacokinetics and clinical studies on cefminox in the field of obstetrics and gynecology]. <i>The Japanese journal of antibiotics</i> 38(5) 1213–1224. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3930789/\">https://pubmed.ncbi.nlm.nih.gov/3930789</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DC12;
